Summary:
- Sanofi, a leading global pharmaceutical company, has announced plans to invest €4 billion in a new research and development (R&D) center in France.
- The new facility will focus on developing innovative treatments for diseases such as cancer, immunology, and neurology, with the goal of improving patient outcomes and advancing the field of medicine.
- This investment is part of Sanofi's broader strategy to strengthen its R&D capabilities and maintain its position as a leader in the pharmaceutical industry.